SCOPUS 정보 검색 플랫폼

Pharmacopsychiatry

Volumn 40, Issue 1, 2007, Pages 41-

Aripiprazole in a therapy-resistant patient with borderline personality and post-traumatic stress disorder

(1) Kellner, M a

a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; MIRTAZAPINE; OLANZAPINE; PAROXETINE; SERTRALINE; VALPROIC ACID; ZIPRASIDONE;

ADULT; AGGRESSION; ANAMNESIS; ARTICLE; BORDERLINE STATE; CASE REPORT; DAYTIME SOMNOLENCE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG USE; DRUG WITHDRAWAL; ENGRAFTMENT SYNDROME; FEMALE; HOMICIDE; HUMAN; IRRITABILITY; NIGHTMARE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; SEDATION; SIDE EFFECT; UNSPECIFIED SIDE EFFECT; WITNESS;

ADULT; ANTIPSYCHOTIC AGENTS; BORDERLINE PERSONALITY DISORDER; DRUG RESISTANCE; FEMALE; HUMANS; PIPERAZINES; PSYCHIATRIC STATUS RATING SCALES; QUINOLONES; STRESS DISORDERS, POST-TRAUMATIC;

EID: 34147136050 PISSN: 01763679 EISSN: None Source Type: Journal
DOI: 10.1055/s-2006-951607 Document Type: Article

Times cited : (5)

References (6)

1
- 14044266829
- Emerging evidence for the use of atypical antipsychotics in borderline personality disorder
- Grootens KP, Verkes RJ: Emerging evidence for the use of atypical antipsychotics in borderline personality disorder. Pharmacopsychiatry 2005; 38: 20-23
- (2005) Pharmacopsychiatry , vol.38 , pp. 20-23
- Grootens, K.P.¹ Verkes, R.J.²

2
- 33745132142
- Aripiprazole pharmacotherapy of borderline personality disorder
- Mosbascher A, Mosbascher J, Schlemper V, Winterer G, Malevani J: Aripiprazole pharmacotherapy of borderline personality disorder. Pharmacopsychiatry 2006; 39: 111-112
- (2006) Pharmacopsychiatry , vol.39 , pp. 111-112
- Mosbascher, A.¹ Mosbascher, J.² Schlemper, V.³ Winterer, G.⁴ Malevani, J.⁵

3
- 85047697000
- Aripiprazole in the treatment of patients with borderline personality disorder: A double-blind, placebo-controlled study
- Nickel MK, Muehlbacher M, Nickel C, Kettler C, Pedrosa Gil F, Bachler E, Buschmann W, Rother N, Fartacek R: Aripiprazole in the treatment of patients with borderline personality disorder: a double-blind, placebo-controlled study. Am J Psychiatry 2006; 163: 833-838
- (2006) Am J Psychiatry , vol.163 , pp. 833-838
- Nickel, M.K.¹ Muehlbacher, M.² Nickel, C.³ Kettler, C.⁴ Pedrosa Gil, F.⁵ Bachler, E.⁶ Buschmann, W.⁷ Rother, N.⁸ Fartacek, R.⁹

4
- 12144281346
- Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patients
- Worthington JJ III, Kinrys G, Wygant LE, Pollack MH: Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patients. Int Clin Psychopharmacol 2005; 20: 9-11
- (2005) Int Clin Psychopharmacol , vol.20 , pp. 9-11
- Worthington III, J.J.¹ Kinrys, G.² Wygant, L.E.³ Pollack, M.H.⁴

5
- 33646680277
- Aripiprazole in the management of post-traumatic stress disorder symptoms in returning Global War on Terrorism vetetans
- Lambert MT: Aripiprazole in the management of post-traumatic stress disorder symptoms in returning Global War on Terrorism vetetans. Int Clin Psychopharmacol 2006; 21: 185-187
- (2006) Int Clin Psychopharmacol , vol.21 , pp. 185-187
- MT, L.¹

6
- 0000649069
- Safety and tolerability of aripiprazole at doses higher than 30 mg
- Saha AR, Ali M, Ingenito GG, Wiber R, Luo X, Bramer S: Safety and tolerability of aripiprazole at doses higher than 30 mg. Int J Neuropsychopharmacol 2002; 5 (Suppl. 1): 185
- (2002) Int J Neuropsychopharmacol , vol.5 , Issue.SUPPL. 1 , pp. 185
- Saha, A.R.¹ Ali, M.² Ingenito, G.G.³ Wiber, R.⁴ Luo, X.⁵ Bramer, S.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.